Research Paper Volume 11, Issue 6 pp 1716—1732
Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients
Figure 6. Diagram depicting the cause of survival difference between left- and right-sided mCRC and the optimal common treatment selection for the patients according to FPR.